Aydin, M. A. Et Al. 2020. Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.. European review for medical and pharmacological sciences , vol.24, no.20 , 10512-10517.

Aydin, M. A., Gul, G., Kiziltan, R., Algul, S., & Kemik, O., (2020). Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.. European review for medical and pharmacological sciences , vol.24, no.20, 10512-10517.

Aydin, M. Et Al. "Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.," European review for medical and pharmacological sciences , vol.24, no.20, 10512-10517, 2020

Aydin, M. A. Et Al. "Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.." European review for medical and pharmacological sciences , vol.24, no.20, pp.10512-10517, 2020

Aydin, M. A. Et Al. (2020) . "Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.." European review for medical and pharmacological sciences , vol.24, no.20, pp.10512-10517.

@article{article, author={M. A. Aydin Et Al. }, title={Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.}, journal={European review for medical and pharmacological sciences}, year=2020, pages={10512-10517} }